RECKITT BENCKISER GROUP PLC ORD
Sentinellis Health Score
7.4/10
GBp 30.1B
GBp 14.2B
9.6x
AI Summary
Reckitt manufactures and sells consumer products in three core segments: germ protection and disinfectants (Dettol, Lysol, Finish), health and personal care (Nurofen, Gaviscon, Mucinex, Durex, Clearasil), and infant nutrition (Enfamil, Nutramigen) [Company Overview]. The company sells globally through retail chains, pharmacies, and e-commerce, serving 36,200 employees across international markets [Company Overview].
Reckitt Benckiser is a UK-based consumer goods giant with a portfolio of household brands including Dettol, Lysol, Finish, Durex, Nurofen, and Enfamil infant formula [Company Overview]. The company generates GBp 14.2B in annual revenue across health, hygiene, and nutrition categories, with a market cap of GBp 30.1B [Yahoo Finance]. Financial health is solid with strong margins and manageable debt, though revenue growth has stalled at just +0.3% year-over-year [Yahoo Finance].
Strong profitability and cash generation with manageable leverage, but revenue growth has flatlined.
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full RECKITT BENCKISER GROUP PLC ORD analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Consumer Defensive) or comparable health.